Titan Pharmaceuticals, Inc. Convertible Debt
Titan Pharmaceuticals, Inc. had Convertible Debt of EUR 550.00 thousand as of 2019-08-31, per its 10-Q filed 2020-05-15.
Discontinued › Balance Sheet › Liabilities › Debt › Long-Term Debt, Unclassified
us-gaap:ConvertibleDebt · last filed 2021-03-31
- 2019-08-31: Convertible Debt 550.00K EUR.
- 2018-08-31: Convertible Debt 550.00K EUR.
- 2018-08-03: Convertible Debt 550.00K EUR.
EUR
| Period end | Convertible Debt |
|---|---|
| 2019-08-31 | 550.00K EUR 10-Q · filed 2020-05-15 |
| 2018-08-31 | 550.00K EUR 10-K · filed 2021-03-31 |
| 2018-08-03 | 550.00K EUR 10-K/A · filed 2019-04-02 |
USD
| Period end | Convertible Debt |
|---|---|
| 2019-08-31 | $600.00K 10-Q · filed 2020-05-15 |
| 2018-08-31 | $600.00K 10-K · filed 2021-03-31 |
| 2018-08-03 | $600.00K 10-K/A · filed 2019-04-02 |